Hedge Fund Managers Discuss Shorting Viasat (VSAT), 2U (TWOU), Long Positions in Microsoft (MSFT), Others
Large hedge funds are required to disclose all of their long stakes in U.S.-traded securities once per quarter.
Sanofi Aventis (SNY)
Market is closed
News
- First
- << Previous
- 131 - 140
- Next >>
Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t
Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory review for IDeglira, with a decision now expected ...
FDA's Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi
We just learnt that the FDA has pushed back its decision day on Sanofi SA (ADR) (NYSE:SNY)’s insulin combo candidate IGlarLixi.
Will Pluristem Therapeutics Inc. (PSTI) Succeed in CLI Where Sanofi SA (ADR) (SNY) Failed?
It’s every junior biotech company’s dream to be accepted into an accelerated approval pathway for a potentially blockbuster drug. Very few achieve it.
The Most Popular French Stocks Among Hedge Funds
French president François Hollande was recently quoted as saying “ça va mieux” of his country's economy, which means that things are improving.
As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs
In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies behind them.
The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362 million, for a growth rate of 28%.
GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market
GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.
Why Sanofi SA (ADR) (SNY) Is Trending on Wednesday
Sanofi SA (ADR) (NYSE:SNY) is preparing to oust all the board members of Medivation, Reuters reported on Wednesday, citing people familiar with the matter.
Warren Buffett’s Best High-Yield Dividend Stocks – May 2016 Update
While Berkshire Hathaway itself does not pay a dividend because it prefers to reinvest all of its earnings for growth, Warren Buffett has certainly not been shy about owning shares of dividend-paying...
- First
- << Previous
- 131 - 140
- Next >>
Billionaire Hedge Funds
